Subscribe
Thx4Stock team / Shutterstock.com
23 January 2025FeaturesAmericasSimon Kiddle and Rebecca Tollervey

ADCs, TCR, and multimodal AI: Transformative trends in 2025

Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Outlook for 2025: how Trump and the USPTO will affect life sciences IP
2 January 2025   Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.
Americas
CREATES Act unfairly tips the scales to generics
19 December 2024   The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.


Editor's picks

Americas
Trump nixes Biden’s Executive Order on drug pricing
21 January 2025

Editor's picks

Americas
Trump nixes Biden’s Executive Order on drug pricing
21 January 2025
Europe
EPO report reveals leading tech investors in Europe
16 January 2025
Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
EOFlow ordered to pay rival $452m over insulin patch trade secrets
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Americas
Outlook for 2025: how Trump and the USPTO will affect life sciences IP
2 January 2025   Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.
Americas
CREATES Act unfairly tips the scales to generics
19 December 2024   The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.

More on this story

Americas
Outlook for 2025: how Trump and the USPTO will affect life sciences IP
2 January 2025   Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.
Americas
CREATES Act unfairly tips the scales to generics
19 December 2024   The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg.

More features

Trump nixes Biden’s Executive Order on drug pricing
Novartis stops rival’s launch of Entresto generic
EPO report reveals leading tech investors in Europe
Takeda loses AMR treatment patent used in kidney transplants
Withers & Rogers hires cell and gene therapy expert
Medtech firm strikes out part of Apple button patent in ECG row
Tissue repair VP gets new trial over secrets damages
Labcorp's bid to invalidate Ravgen's DNA testing patent hits roadblock